Enterobacter cloacae inhibitors are chemical compounds that are designed to target and inhibit the activity of the bacterial species Enterobacter cloacae. This bacterium is a Gram-negative rod-shaped microorganism that belongs to the Enterobacteriaceae family. Inhibitors of this bacterium work by targeting various aspects of its cellular machinery, such as enzymes involved in essential processes like cell wall synthesis, DNA replication, or metabolic pathways specific to the bacterium. The goal of these inhibitors is to impede the growth and proliferation of Enterobacter cloacae by disrupting its biological functions, which are crucial for its survival and propagation. These inhibitors can be diverse in their chemical structure and mechanisms of action, and they may belong to different classes, including small molecules, peptides, or complex macromolecules. The efficacy of these inhibitors is often measured by their ability to specifically and efficiently target Enterobacter cloacae without affecting other bacterial species or host cells.
The development of Enterobacter cloacae inhibitors requires a detailed understanding of the bacterium's unique biological pathways and structures that are absent or markedly different in non-target organisms. For example, some inhibitors may function by binding to bacterial enzymes such as β-lactamases, which are involved in antibiotic resistance mechanisms, or by interfering with membrane transport proteins that are critical for the uptake of nutrients. The chemical properties of these inhibitors-such as molecular size, polarity, and solubility-play a key role in their ability to interact with bacterial targets effectively. Researchers often employ a variety of biochemical and structural biology techniques to identify binding sites and elucidate the mode of action of these inhibitors, enabling the optimization of their binding affinity and selectivity for Enterobacter cloacae. Due to the diverse nature of potential targets within the bacterial cell, Enterobacter cloacae inhibitors can have a wide range of structures and functional groups, making their study a complex but crucial area of chemical research for understanding bacterial growth control mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $42.00 | 8 | |
Ciprofloxacin could directly inhibit the DNA gyrase of Enterobacter cloacae, leading to a blockade of DNA replication and transcription processes, thereby decreasing bacterial proliferation and gene expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin has the potential to bind selectively to bacterial RNA polymerase, which would inhibit the initiation of RNA synthesis in Enterobacter cloacae, reducing mRNA production for protein synthesis. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $82.00 | ||
This compound could inhibit several bacterial enzymes, which might lead to a disruption of DNA, RNA, and cell wall synthesis in Enterobacter cloacae, thereby decreasing its gene expression and multiplication. | ||||||
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $138.00 $400.00 | ||
By inhibiting the enoyl-acyl carrier protein reductase, Triclosan might decrease the synthesis of fatty acids necessary for cell membrane biosynthesis in Enterobacter cloacae, reducing cell growth and function. | ||||||
Sulfamethoxazole | 723-46-6 | sc-208405 sc-208405A sc-208405B sc-208405C | 10 g 25 g 50 g 100 g | $36.00 $54.00 $68.00 $107.00 | 5 | |
Sulfamethoxazole might competitively inhibit dihydropteroate synthase, an enzyme involved in folate synthesis, which could lead to a reduction in thymidine and purine production, and consequently, a decrease in DNA synthesis in Enterobacter cloacae. | ||||||
Trimethoprim | 738-70-5 | sc-203302 sc-203302A sc-203302B sc-203302C sc-203302D | 5 g 25 g 250 g 1 kg 5 kg | $66.00 $158.00 $204.00 $707.00 $3334.00 | 4 | |
Working synergistically with sulfamethoxazole, Trimethoprim could inhibit dihydrofolate reductase, leading to a decrease in tetrahydrofolate and resulting in inhibited DNA replication and transcription in Enterobacter cloacae. | ||||||
Chlorhexidine | 55-56-1 | sc-252568 | 5 g | $101.00 | 3 | |
Chlorhexidine might compromise membrane integrity by precipitating membrane proteins and disrupting osmotic equilibrium in Enterobacter cloacae, leading to a decrease in cellular function and gene expression. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Hydrogen peroxide could induce oxidative stress in Enterobacter cloacae cells, which might damage DNA and other cellular components, leading to the inhibition of cellular replication and gene expression. | ||||||